section name header

Y-Site Injection Compatibility (1:1 Mixture)

Cefiderocol sulfate tosylate

(Mfr: SHI)(Conc: 20 mg/mLa)

QMark

Morphine sulfate

(Mfr: HOS)(Conc: 15 mg/mLa)

Remarks:

Results of subvisual tests indicate high counts of particles =25 and =50 µm when cefiderocol is added to morphine; not observed when order of mixing was reversed

Ref:

3662